BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32593597)

  • 1. Editorial: Cerebral Embolic Protection for TAVR: Don't Let It Go to Your Head.
    Goldsweig AM; Aronow HD
    Cardiovasc Revasc Med; 2020 Jun; 21(6):723-725. PubMed ID: 32593597
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebral Embolic Protection in Transcatheter Aortic Valve Replacement: Connecting Intuition and Proof.
    Kapadia SR; Krishnaswamy A
    JACC Cardiovasc Interv; 2021 Jan; 14(2):169-171. PubMed ID: 33478632
    [No Abstract]   [Full Text] [Related]  

  • 3. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
    Latib A; Mangieri A; Vezzulli P; Spagnolo P; Sardanelli F; Fellegara G; Pagnesi M; Giannini F; Falini A; Gorla R; Montorfano M; Bedogni F; Colombo A; Popma J; Merhi WM; De Marco F
    JACC Cardiovasc Interv; 2020 Apr; 13(7):860-868. PubMed ID: 32273098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral embolic protection systems for transcatheter aortic valve replacement.
    Gasior T; Mangner N; Bijoch J; Wojakowski W
    J Interv Cardiol; 2018 Dec; 31(6):891-898. PubMed ID: 30467892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.
    Van Gils L; Kroon H; Daemen J; Ren C; Maugenest AM; Schipper M; De Jaegere PP; Van Mieghem NM
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):790-797. PubMed ID: 28895285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.
    Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection from Cerebral Embolic Events During Transcatheter Aortic Valve Replacement.
    Rossow CF; McCabe JM
    Curr Cardiol Rep; 2016 Feb; 18(2):16. PubMed ID: 26768742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcarotid transcatheter aortic valve replacement with cerebral embolic protection.
    McGrath D; Salehi P; Weintraub A; Zhan Y
    J Card Surg; 2022 Jun; 37(6):1779-1782. PubMed ID: 35301761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral Embolic Protection and Stroke-Related Mortality Following Transcatheter Aortic Valve Replacement.
    Isogai T; Bansal A; Vanguru HR; Agrawal A; Shekhar S; Puri R; Reed GW; Krishnaswamy A; Uchino K; Kapadia SR
    JACC Cardiovasc Interv; 2022 Mar; 15(5):569-571. PubMed ID: 35272784
    [No Abstract]   [Full Text] [Related]  

  • 10. Early Clinical Impact of Cerebral Embolic Protection in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Kroon HG; van der Werf HW; Hoeks SE; van Gils L; van den Berge FR; El Faquir N; Rahhab Z; Daemen J; Poelman J; Schurer RAJ; van den Heuvel A; de Jaegere P; van der Harst P; Van Mieghem NM
    Circ Cardiovasc Interv; 2019 Jun; 12(6):e007605. PubMed ID: 31195822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embolic protection in patients undergoing transaortic transcatheter aortic valve replacement: initial experience with the TriGuard HDH embolic deflection device.
    Campelo-Parada F; Regueiro A; Dumont E; DeLarochellière R; Paradis JM; Mohammadi S; Doyle D; Rodés-Cabau J
    J Card Surg; 2016 Oct; 31(10):617-622. PubMed ID: 27577965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-Analysis of Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement.
    Nazir S; Zafrullah F; Virk HUH; Sandhu CS; Ameen M; Ahuja KR
    Am J Cardiol; 2021 Jan; 139():138-139. PubMed ID: 33164763
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebral Embolic Protection Devices for Transcatheter Aortic Valve Replacement: Review of the Literature and Future Perspectives.
    Ng S; Cunningham T; Vavalle JP
    Curr Cardiol Rep; 2024 May; 26(5):339-347. PubMed ID: 38472629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During Transcatheter Aortic Valve Replacement.
    Schmidt T; Leon MB; Mehran R; Kuck KH; Alu MC; Braumann RE; Kodali S; Kapadia SR; Linke A; Makkar R; Naber C; Romero ME; Virmani R; Frerker C
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1262-1273. PubMed ID: 29976363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a Two-Filter Cerebral Embolic Protection Device on the Complexity and Risk of Transcatheter Aortic Valve Replacement.
    Voss S; Deutsch MA; Schechtl J; Erlebach M; Sideris K; Lange R; Bleiziffer S
    Thorac Cardiovasc Surg; 2020 Oct; 68(7):616-622. PubMed ID: 31091551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TriGuard
    Samim M; van der Worp B; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Ramjankhan F; Doevendans PA; Stella PR
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):470-477. PubMed ID: 27121306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant Differences in Debris Captured by the Sentinel Dual-Filter Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Among Different Valve Types.
    Seeger J; Virmani R; Romero M; Gonska B; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2018 Sep; 11(17):1683-1693. PubMed ID: 30154060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurologic Events Risk Prediction and Embolic Protection Devices in TAVR.
    Condello I; Rimmaudo F
    Ann Thorac Surg; 2022 Nov; 114(5):1977-1978. PubMed ID: 35031294
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebral protection devices during transcatheter aortic valve implantation.
    Vlastra W; Vendrik J; Koch KT; Baan J; Piek JJ; Delewi R
    Trends Cardiovasc Med; 2018 Aug; 28(6):412-418. PubMed ID: 29428159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Cerebral Embolic Capture Using the SENTINEL Device During Transcatheter Aortic Valve Implantation in Low to Intermediate-Risk Patients: The SENTINEL-LIR Study.
    Kawakami R; Gada H; Rinaldi MJ; Nazif TM; Leon MB; Kapadia S; Krishnaswamy A; Sakamoto A; Sato Y; Mori M; Kawai K; Cornelissen A; Park JE; Ghosh SKB; Abebe BG; Romero M; Virmani R; Finn AV
    Circ Cardiovasc Interv; 2022 Apr; 15(4):e011358. PubMed ID: 35272475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.